Bruce Altevogt

VP and Head External Medical Engagement, Hospital Business Unit at Pfizer, USA

Speaker

Bruce Altevogt is Vice President and Head External Medical Engagement, responsible for establishing and managing patient and medical stakeholder engagement strategy for antimicrobial resistance (AMR) and COVID-19. In addition, his team leads Pfizer’s antimicrobial stewardship strategy, including management of the industry leading AMR surveillance program, ATLAS.

Dr. Altevogt serves as a member of the Boards for Healthcare Ready and the AMR Industry Alliance Board.

Prior to joining Pfizer Inc. Dr. Altevogt served as a senior program officer on the Board on Health Sciences Policy at the National Academy of Medicine

Dr. Altevogt received a doctorate from Harvard University’s Program in Neuroscience and a B.A. from the University of Virginia.